The etiology and possible molecular mechanisms underlying calcium channel blocker-induced gingival enlargement: a narrative review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Gingival enlargement, defined as the abnormal proliferation of gingival tissue, can be caused by exposure to poor oral hygiene, periodontal diseases, or systemic drugs such as antihypertensive, immunosuppressive, and anticonvulsant agents. Although numerous clinical studies have examined drug-induced gingival enlargement, there is limited evidence on the molecular mechanisms underlying this disease. Therefore, the current study aims to summarize the available literature on the effects of systemic drugs such as antihypertensive agents and calcium channel blockers used for the treatment of cardiac diseases on gingival enlargement expression, and to discuss possible molecular mechanisms underlying drug-induced gingival enlargement.
Abstract
Gingival enlargement, defined as the abnormal proliferation of gingival tissue, can be caused by exposure to poor oral hygiene, periodontal diseases, or systemic drugs such as antihypertensive, immunosuppressive, and anticonvulsant agents. Although numerous clinical studies have examined drug-induced gingival enlargement, there is limited evidence on the molecular mechanisms underlying this disease. Therefore, the current study aims to summarize the available literature on the effects of systemic drugs such as antihypertensive agents and calcium channel blockers used for the treatment of cardiac diseases on gingival enlargement expression, and to discuss possible molecular mechanisms underlying drug-induced gingival enlargement.
참고문헌 (26)
- 서조영, "약물유발 치은비대증의 비외과적 치료", 대한치과의사협회지, 46(6), pp.362~369 (2008), 대한치과의사협회[DOI]
- 안양희, "고혈압관리를 위한 고혈압환자 유형별 특성 - 투약과 건강생활양식의 지식, 태도, 행위를 기반으로 -", 지역사회간호학회지, 18(1), pp.112~122 (2007), 한국지역사회간호학회
- Papadopoulos DP, "Hypertension crisis", Blood Press, 19, pp.328~336 (2010)[DOI]
- 심봉섭, "고혈압의 약물 치료", Journal of Yeungnam Medical Science, 6(2), pp.1~11 (1989), 영남대학교 의과대학[DOI]
- Tonetti MS, "Staging and grading of periodontitis : framework and proposal of a new classification and case definition", J Periodontol, 89(Suppl 1), pp.S159~S172 (2018)[DOI]
- Papapanou PN, "Periodontitis : consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions", J Periodontol, 89(Suppl 1 : S173-S182. doi), pp.S173~S182 (2018)[DOI]
- Caton JG, "A new classification scheme for periodontal and periimplant diseases and conditions-introduction and key changes from the 1999 classification", J Clin Periodontol, 45(Suppl 20 : S1-S8. doi), pp.S1~S8 (2018)[DOI]
- The Council of the Faculty of Periodontology, "Periodontology", pp.86~ (2015), Koonja Publishing Inc
- Babcock JR, "Incidence of gingival hyperplasia associated with Dilantin therapy in a hospital population", J Am Dent Assoc, 71, pp.1447~1450 (1965)[DOI]
- Angelopoulos AP, "Incidence of diphenylhydantoin gingival hyperplasia", Oral Surg Oral Med Oral Pathol, 34, pp.898~906 (1972)[DOI]
- Somacarrera ML, "Factors related to the incidence and severity of cyclosporininduced gingival overgrowth in transplant patients. A longitudinal study", J Periodontol, 65, pp.671~675 (1994)[DOI]
- Barclay S, "The incidence and severity of nifedipine-induced gingival overgrowth", J Clin Periodontol, 19, pp.311~314 (1992)[DOI]
- 이성진, "장기간 Amlodipine 복용 후 발생한 심한 잇몸 과증식 1예", 대한내과학회지, 82(5), pp.623~627 (2012), 대한내과학회[DOI]
- Naruishi K, "Biological effects of interleukin-6 on gingival fibroblasts : cytokine regulation in periodontitis", J Cell Physiol, 233, pp.6393~6400 (2018)[DOI]
- Chatzopoulos GS, "Systematic review of cyclosporin A-induced gingival overgrowth and genetic predisposition", Quintessence Int, 48, pp.711~724 (2017)[DOI]
- Luchian I, "The role of matrix metalloproteinases(MMP-8, MMP-9, MMP-13)in periodontal and peri-implant pathological processes", Int J Mol Sci, 23, pp.1806~ (2022)[DOI]
- Zervoudaki A, "The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and-9 in essential hypertension", Am J Hypertens, 17, pp.273~276 (2004)[DOI]
- 김상준, "치은비대에서 비외과적 치료의 효과", Journal of Periodontal & Implant Science, 39(1), pp.103~108 (2009), 대한치주과학회
- Mawardi H, "Management of medication-induced gingival hyperplasia : a systematic review", Oral Surg Oral Med Oral Pathol Oral Radiol, 131, pp.62~72 (2021)[DOI]
- 유장배, "Amlodipine으로 인한 임플란트 주위 조직의 비대", Journal of Periodontal & Implant Science, 35(3), pp.591~596 (2005), 대한치주과학회
- Chang CC, "Nonsurgical periodontal treatment and prosthetic rehabilitation of a renal transplant patient with gingival enlargement : a case report with 2-year follow-up", BMC Oral Health, 18, pp.140~ (2018)[DOI]
- Chiang CY, "Cyclosporin-A inhibits the expression of cyclooxygenase-2 in gingiva", J Periodontal Res, 42, pp.443~449 (2007)[DOI]
- Modéer T, "Enhanced prostaglandin biosynthesis in human gingival fibroblasts isolated from patients treated with phenytoin", J Oral Pathol Med, 21, pp.251~255 (1992)[DOI]
- Cacabelos R, "The role of pharmacogenomics in adverse drug reactions", Expert Rev Clin Pharmacol, 12, pp.407~442 (2019)[DOI]
- Weinshilboum RM, "Pharmacogenomics : precision medicine and drug response", Mayo Clin Proc, 92, pp.1711~1722 (2017)[DOI]
- Cecchin E, "Pharmacogenomics and personalized medicine", Genes(Basel), 11, pp.679~ (2020)[DOI]